J&J Pays $2M To Exit Idaho AG's Drug Pricing Suit

Law360, New York (December 6, 2011, 4:02 PM EST) -- Johnson & Johnson has agreed to fork over $2 million to put to rest claims the company caused overcharges to the Idaho Medicaid program by publishing inflated average wholesale prices for its drugs, the Idaho Attorney General's Office said Tuesday.

J&J is one of many drugmakers targeted over inflated AWPs in lawsuits brought by state attorneys general across the country. The attorneys general say their states' Medicaid programs used drugmakers' allegedly inflated AWPs to calculate how much to reimburse pharmacies for prescription drugs.

An Idaho state...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.